TrialActa haematologica2024

Zanubrutinib plus Cytarabine in Patients with Refractory/Relapsed Primary Central Nervous System Lymphoma.

Zhiguang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.